Procedures and methods of benefit assessments for medicines in Germany: give the child a name

Eur J Health Econ. 2009 May;10(2):237-8. doi: 10.1007/s10198-009-0147-4.

Authors

Holger Schünemann¹, Regina Kunz, Yngve Falck-Ytter, Nancy Santesso

Affiliation

¹ Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre, Room 2C10B, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada. [email protected]

PMID: 19290557
DOI: 10.1007/s10198-009-0147-4

No abstract available

Publication types

Letter

MeSH terms

Cost-Benefit Analysis
Evidence-Based Medicine / standards*
Germany
National Health Programs / standards*
Pharmaceutical Preparations / standards*
Product Surveillance, Postmarketing

Substances

Pharmaceutical Preparations